Patent · US Active

BTLA agonist antibodies and uses thereof

US10604573B2 · kind B2 · utility

0Cited by

3References

9Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Shane Krummen Atwell · Carlsbad, US
Andrew Charles Vendel · San Diego, US
Victor H. Obungu · Fishers, US

Key dates

Filing date	May 11, 2018
Grant date	Mar 31, 2020
Priority date	—
Expiry date	Aug 14, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies which bind BTLA, and methods of using same, are provided, said antibodies are useful as agents for treating conditions associated with autoimmune disease including treating lupus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.